Cyclopharm Limited (AU:CYC)
ASX:CYC
Australian Market
Holding AU:CYC?
Track your performance easily

Cyclopharm Limited (CYC) Financial Statements

5 Followers

Cyclopharm Limited Financial Overview

Cyclopharm Limited's market cap is currently ―. The company's EPS TTM is AU$-0.097; its P/E ratio is -14.46; Cyclopharm Limited is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 20.30MAU$ 29.25MAU$ 1.87MAU$ 12.66MAU$ 5.85M
Total AssetsAU$ 49.54MAU$ 55.74MAU$ 28.28MAU$ 32.53MAU$ 23.54M
Total DebtAU$ 4.33MAU$ 4.51MAU$ 4.71MAU$ 4.92MAU$ 120.58K
Net DebtAU$ -15.96MAU$ -24.74MAU$ 2.83MAU$ -7.74MAU$ -5.73M
Total LiabilitiesAU$ 13.01MAU$ 12.67MAU$ 11.16MAU$ 9.32MAU$ 6.52M
Stockholders EquityAU$ 36.54MAU$ 43.07MAU$ 17.12MAU$ 23.20MAU$ 17.02M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Cyclopharm Limited Earnings and Revenue History

Cyclopharm Limited Debt to Assets

Cyclopharm Limited Cash Flow

Cyclopharm Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis